JP2024502295A5 - - Google Patents
Info
- Publication number
- JP2024502295A5 JP2024502295A5 JP2023539028A JP2023539028A JP2024502295A5 JP 2024502295 A5 JP2024502295 A5 JP 2024502295A5 JP 2023539028 A JP2023539028 A JP 2023539028A JP 2023539028 A JP2023539028 A JP 2023539028A JP 2024502295 A5 JP2024502295 A5 JP 2024502295A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- cancer cells
- electric field
- pharmaceutical composition
- alternating electric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063130449P | 2020-12-24 | 2020-12-24 | |
| US63/130,449 | 2020-12-24 | ||
| PCT/IB2021/062198 WO2022137171A2 (en) | 2020-12-24 | 2021-12-22 | Methods and compositions for using alternating electric fields in gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502295A JP2024502295A (ja) | 2024-01-18 |
| JP2024502295A5 true JP2024502295A5 (cg-RX-API-DMAC7.html) | 2025-01-07 |
Family
ID=80121763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023539028A Pending JP2024502295A (ja) | 2020-12-24 | 2021-12-22 | 遺伝子治療において交流電場を使用するための方法及び組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220203088A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4267236B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024502295A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116615268A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022137171A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7886853B2 (ja) * | 2020-09-18 | 2026-07-08 | ノボキュア ゲーエムベーハー | コロナウイルスを処置するための方法及び組成物 |
| JP2025520663A (ja) * | 2022-06-21 | 2025-07-03 | ノボキュア ゲーエムベーハー | 交流電場とcrispr-casシステムを用いた症状および疾患の治療システムおよび方法 |
| CN115845254B (zh) * | 2022-11-23 | 2024-02-02 | 湖南安泰康成生物科技有限公司 | 小细胞肺癌治疗系统以及交变电场发生装置 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| DE3681787D1 (de) | 1985-07-05 | 1991-11-07 | Whitehead Biomedical Inst | Expression von fremdem genetischem material in epithelzellen. |
| DE68927996T2 (de) | 1988-02-05 | 1997-12-04 | Hughes Howard Med Inst | Modifizierte hepatozyten und deren anwendung |
| WO1990002806A1 (en) | 1988-09-01 | 1990-03-22 | Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
| US6261834B1 (en) | 1991-11-08 | 2001-07-17 | Research Corporation Technologies, Inc. | Vector for gene therapy |
| WO1999011771A1 (en) * | 1997-09-04 | 1999-03-11 | Science Research Laboratory, Inc. | Cell separation using electric fields |
| SE9704076D0 (sv) * | 1997-11-06 | 1997-11-06 | Holdingbolaget Vid Goeteborgs | Method for permeabilisation of cell structures and use thereof |
| US7016725B2 (en) | 2001-11-06 | 2006-03-21 | Standen Ltd. | Method and apparatus for destroying dividing cells |
| US8447395B2 (en) | 2000-02-17 | 2013-05-21 | Novocure Ltd | Treating bacteria with electric fields |
| US20040092860A1 (en) * | 2000-07-26 | 2004-05-13 | Dev Nagendu B. | Skin and muscle-targeted gene therapy by pulsed electrical field |
| WO2005115535A2 (en) | 2004-04-23 | 2005-12-08 | Novocure Ltd. | Treating a tumor or the like with electric fields at different frequencies |
| CN102488967B (zh) * | 2004-12-27 | 2016-03-30 | 诺沃库勒有限公司 | 利用电场从不同方向治疗肿瘤等 |
| EP3143124B1 (en) * | 2014-05-12 | 2025-01-22 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
| US20200308560A1 (en) * | 2017-06-26 | 2020-10-01 | The Broad Institute, Inc. | Novel type vi crispr orthologs and systems |
| KR102793500B1 (ko) * | 2018-05-02 | 2025-04-14 | 그랜드 디케이드 디벨로프먼츠 리미티드 | 전기천공 시스템, 방법, 및 장치 |
| KR102870236B1 (ko) * | 2018-07-03 | 2025-10-14 | 에드윈 창 | 세포막 투과성을 향상시키기 위한 교류 전기장 사용 |
| WO2020047387A1 (en) * | 2018-08-31 | 2020-03-05 | Thomas Jefferson University | In vivo genetic engineering of antigen responsive cells |
| CN113164525B (zh) * | 2018-10-23 | 2025-03-14 | 利兰·斯坦福青年大学托管委员会 | 在基于干细胞的疗法中使用交变电场预防和治疗畸胎瘤形成 |
-
2021
- 2021-12-22 JP JP2023539028A patent/JP2024502295A/ja active Pending
- 2021-12-22 EP EP21851628.4A patent/EP4267236B1/en active Active
- 2021-12-22 US US17/559,228 patent/US20220203088A1/en active Pending
- 2021-12-22 CN CN202180086830.9A patent/CN116615268A/zh active Pending
- 2021-12-22 WO PCT/IB2021/062198 patent/WO2022137171A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107075515B (zh) | C/EBPα组合物和使用方法 | |
| Kretzmann et al. | Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers | |
| US20210206818A1 (en) | Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof | |
| Wang et al. | A photoresponsive antibody–siRNA conjugate for activatable immunogene therapy of cancer | |
| US20060211637A1 (en) | Methods of down regulating target gene expression in vivo by introduction of interfering rna | |
| Fujita et al. | A novel platform to enable inhaled naked RNAi medicine for lung cancer | |
| EP4317440A1 (en) | Viral vector-based rna delivery system and use thereof | |
| JP2008537752A (ja) | がんおよび他の新血管形成疾患を処置するためのRNAi治療用の組成物および方法 | |
| Jia et al. | VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma | |
| JP2021519296A5 (cg-RX-API-DMAC7.html) | ||
| CN107365785B (zh) | 一种调控细胞内NF-κB活性的基因表达载体及其调控方法和应用 | |
| Yang et al. | The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies | |
| CN109563513B (zh) | 一种抑制K-RAS基因表达的siRNA及其前体和应用 | |
| WO2017190695A1 (zh) | 一种抑制EGFR基因表达的siRNA及其前体和应用 | |
| JP2024511525A (ja) | Rnaプラスミド送達システム及びその使用 | |
| Takei et al. | In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency | |
| WO2019123414A1 (en) | Engineered viruses expressing cyclic gmp-amp synthase | |
| US20160220599A1 (en) | Novel lincrna and interfering nucleic acid molecules, compositions and methods and uses thereof for regulating angiogenesis and related conditions | |
| KR101286053B1 (ko) | TGF-β1 발현을 억제하는 shRNA | |
| CN120958133A (zh) | 合成回路及其用途 | |
| Jesenko et al. | Effective targeting of E2F1 transcription factor via siRNA gene electrotransfer in HT-29 colorectal carcinoma xenografts | |
| JP2025516226A5 (cg-RX-API-DMAC7.html) | ||
| CN117257970A (zh) | 靶向抑制表皮生长因子受体的递送系统及其在制备抗肿瘤产品中的应用 | |
| KR101374585B1 (ko) | HSP27 발현을 억제하는 shRNA | |
| JP2025504518A (ja) | 改善された活性を有する修飾トランスファーrna |